SIRPA and neoplasm: CD47 is an innate immune checkpoint that interacts with receptor signaling regulatory protein α (SIRPα), thereby inhibiting phagocytosis by macrophages, and inhibition of the CD47/SIRPα signaling pathway may also limit tumor growth [92,93].